Healthcare provider profile · identity verified

Stanton Keith Collins, M.D.

Internal Medicine · BRONX, NY · NPI 1003178765

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	579	199
Amlodipine Besylate	Amlodipine Besylate	378	118
Lisinopril	Lisinopril	337	122
Omeprazole	Omeprazole	235	86
Metoprolol Succinate	Metoprolol Succinate	211	66
Losartan Potassium	Losartan Potassium	203	66
Gabapentin	Gabapentin	198	53
Levothyroxine Sodium	Levothyroxine Sodium	196	63
Metformin Hcl	Metformin Hcl	190	65
Albuterol Sulfate Hfa	Albuterol Sulfate	184	59
Hydrochlorothiazide	Hydrochlorothiazide	175	60
Trazodone Hcl	Trazodone Hcl	169	44
Simvastatin	Simvastatin	167	59
Eliquis	Apixaban	153	35
Atenolol	Atenolol	130	38
Tamsulosin Hcl	Tamsulosin Hcl	126	49
Rosuvastatin Calcium	Rosuvastatin Calcium	111	35
Lorazepam	Lorazepam	110	28
Metoprolol Tartrate	Metoprolol Tartrate	93	25
Pravastatin Sodium	Pravastatin Sodium	91	29
Pantoprazole Sodium	Pantoprazole Sodium	86	29
Clonazepam	Clonazepam	84	13
Sertraline Hcl	Sertraline Hcl	83	25
Tramadol Hcl	Tramadol Hcl	78	17
Furosemide	Furosemide	66	24
Fluticasone Propionate	Fluticasone Propionate	64	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	64	suppressed
Allopurinol	Allopurinol	61	22
Oxycodone Hcl	Oxycodone Hcl	54	suppressed
Alendronate Sodium	Alendronate Sodium	51	18
Citalopram Hbr	Citalopram Hydrobromide	51	14
Famotidine	Famotidine	50	25
Duloxetine Hcl	Duloxetine Hcl	42	11
Montelukast Sodium	Montelukast Sodium	40	13
Meloxicam	Meloxicam	39	11
Jardiance	Empagliflozin	38	14
Alprazolam	Alprazolam	36	suppressed
Clonidine Hcl	Clonidine Hcl	36	13
Pioglitazone Hcl	Pioglitazone Hcl	36	14
Diclofenac Sodium	Diclofenac Sodium	35	18
Meclizine Hcl	Meclizine Hcl	35	24
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Ozempic	Semaglutide	33	suppressed
Prednisone	Prednisone	33	22
Nabumetone	Nabumetone	32	18
Metformin Hcl Er	Metformin Hcl	31	14
Farxiga	Dapagliflozin Propanediol	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Carvedilol	Carvedilol	29	11
Pregabalin	Pregabalin	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	29	14
Betamethasone Dipropionate	Betamethasone Dipropionate	28	18
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	12
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	17
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Valsartan	Valsartan	25	suppressed
Ezetimibe	Ezetimibe	24	11
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Ibuprofen	Ibuprofen	23	11
Memantine Hcl	Memantine Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	22
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	13
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Azithromycin	Azithromycin	20	15
Glipizide	Glipizide	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Bupropion Hcl	Bupropion Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Baclofen	Baclofen	17	suppressed
Colchicine	Colchicine	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Diazepam	Diazepam	15	suppressed
Linzess	Linaclotide	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error